Página principalNBIX • NASDAQ
add
Neurocrine Biosciences
Cierre anterior
$136.70
Intervalo del día
$137.35 - $138.69
Intervalo anual
$89.04 - $148.37
Cap. bursátil
13.85 mil M USD
Volumen prom.
768.02 k
Relación precio‑beneficio
37.82
Rendimiento por dividendos
-
Mercado primario
NASDAQ
Finanzas
Estado de ingresos
Ingresos
Ingresos netos
| (USD) | mar 2024info | Cambio interanual |
|---|---|---|
Ingresos | 515.30 M | 22.57% |
Gastos de operación | 243.10 M | 0.16% |
Ingresos netos | 43.40 M | 156.66% |
Margen de utilidad neta | 8.42 | 146.21% |
Ganancias por acción | 1.20 | 335.29% |
EBITDA | 111.50 M | 221.33% |
Tasa impositiva vigente | -25.80% | — |
Balance general
Activos totales
Pasivos totales
| (USD) | mar 2024info | Cambio interanual |
|---|---|---|
Inversiones plazo/efectivo | 1210.60 M | 35.32% |
Activos totales | 3472.40 M | 47.15% |
Pasivos totales | 1086.30 M | 60.86% |
Acciones totales | 2386.10 M | — |
Acciones en circulación | 100.64 M | — |
Precio/valor contable | 5.76 | — |
Rendimiento de los activos | 7.83% | — |
Rendimiento del capital | 9.59% | — |
Flujo de efectivo
Variación neta en caja
| (USD) | mar 2024info | Cambio interanual |
|---|---|---|
Ingresos netos | 43.40 M | 156.66% |
Efectivo de operaciones | 130.30 M | 204.07% |
Efectivo de inversiones | -55.00 M | -30.64% |
Efectivo de financiación | 69.90 M | 752.44% |
Variación neta en caja | 145.20 M | 191.26% |
Flujo de efectivo libre | 282.72 M | 996.83% |
Acerca de
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine was approved in the US to treat adults with tardive dyskinesia.
The company is also developing treatments that are in various stages of clinical research for Parkinson's disease, Tourette syndrome, and congenital adrenal hyperplasia and with a partner for endometriosis and uterine fibroids. Wikipedia
Director general
Fecha de fundación
1992
Sede principal
Sitio web
Cantidad de empleados
1,448
